KAYLA HOLLIHAN, APRN
Family Nurse Practitioner · BOYNTON BEACH, FL
Individual Active NPI 1265151625
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 309 | 215,178 | $16,955,249 | $5,834,876 | $4,644,553 |
| 2023 | 136 | 76,625 | $6,492,960 | $1,974,704 | $1,571,646 |
| 2022 | 22 | 9,365 | $777,535 | $227,249 | $181,060 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2356 | Injection, tezepelumab-ekko, 1 mg | 32,550 | $18 | $14 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 27,600 | $22 | $17 |
| J1306 | Injection, inclisiran, 1 mg | 18,460 | $12 | $10 |
| J2182 | Injection, mepolizumab, 1 mg | 14,800 | $30 | $24 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 9,300 | $18 | $14 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 7,741 | $44 | $35 |
| J2357 | Injection, omalizumab, 5 mg | 5,850 | $37 | $30 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 3,686 | $0 | $0 |
| J3245 | Injection, tildrakizumab, 1 mg | 3,600 | $135 | $108 |
| J0517 | Injection, benralizumab, 1 mg | 1,530 | $165 | $131 |
| 96372 | Injection of drug or substance under skin or into muscle | 586 | $12 | $10 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 219 | $107 | $85 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 11021130 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Florida
- NPI 1043694656
- NPI 1588291637
- NPI 1447969316
- NPI 1619528221
- NPI 1659025153
- NPI 1235721416
- NPI 1518367374
- NPI 1548909963
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.